이 에피소드에 관해
Renforth Resources Inc (CSE:RFR, OTCQB:RFHRF) CEO Nicole Brewster spoke with Proactive's Stephen Gunnion about new gold intersections at its Parbec deposit in Quebec, the planned resource review and next steps towards assessing development options.
Two drillholes beneath recent surface discoveries intersected gold, including 9.41 grams per tonne over 4.05 metres and 15.68 grams per tonne over 0.85 metres. The results extend mineralisation into areas not previously tested by drilling within the existing open-pit footprint.
Brewster discussed how the new drilling and surface channel samples could feed into an internal resource model update. The review will also consider a higher gold-price assumption than the US$2,100 per ounce used in the April 2025 estimate. The impact remains to be quantified.
Next steps include further assay work, geological modelling and metallurgical testing to assess whether the deposit could suit a toll-milling scenario. Renforth is also considering further surface stripping and channel sampling to better define mineralisation.
Watch the full interview to hear Brewster discuss the new gold intersections and Renforth’s plans for Parbec.
Visit Proactive's YouTube channel for more mining company interviews, gold exploration updates and resource sector news. Don't forget to like the video, subscribe to the channel and enable notifications for future content.
Read Proactive's Editorial Policy here: https://www.proactiveinvestors.co.uk/pages/editorialPolicy
#RenforthResources #NicoleBrewster #GoldExploration #GoldMining #GoldDrilling #Parbec #GoldDiscoveries #HighGradeGold #GoldResources #MineralExploration #ResourceDevelopment #CanadianMining #GoldInvesting #MiningStocks #Metallurgy #TollMilling #ProactiveInvestors
Two drillholes beneath recent surface discoveries intersected gold, including 9.41 grams per tonne over 4.05 metres and 15.68 grams per tonne over 0.85 metres. The results extend mineralisation into areas not previously tested by drilling within the existing open-pit footprint.
Brewster discussed how the new drilling and surface channel samples could feed into an internal resource model update. The review will also consider a higher gold-price assumption than the US$2,100 per ounce used in the April 2025 estimate. The impact remains to be quantified.
Next steps include further assay work, geological modelling and metallurgical testing to assess whether the deposit could suit a toll-milling scenario. Renforth is also considering further surface stripping and channel sampling to better define mineralisation.
Watch the full interview to hear Brewster discuss the new gold intersections and Renforth’s plans for Parbec.
Visit Proactive's YouTube channel for more mining company interviews, gold exploration updates and resource sector news. Don't forget to like the video, subscribe to the channel and enable notifications for future content.
Read Proactive's Editorial Policy here: https://www.proactiveinvestors.co.uk/pages/editorialPolicy
#RenforthResources #NicoleBrewster #GoldExploration #GoldMining #GoldDrilling #Parbec #GoldDiscoveries #HighGradeGold #GoldResources #MineralExploration #ResourceDevelopment #CanadianMining #GoldInvesting #MiningStocks #Metallurgy #TollMilling #ProactiveInvestors
영어
미국
전사 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
이 팟캐스트의 다른 에피소드
Gelion PLC (AIM:GELN, OTC:GELNF, FRA:X0S) CEO Matt Wood and CFO Amit Gupta spoke with Proactive's Stephen Gunnion after the battery technology company delivered FY2026 results ahead of market expectations and advanced plans to commercialise its nano-encapsulated sulfur (NES) technology.
Gupta repo…
Immunic Inc (NASDAQ:IMUX, FRA:10VA) CEO Erik Lundgren joined Proactive's Stephen Gunnion to discuss four posters the company will present at MSToronto2026, the 10th Joint ACTRIMS-ECTRIMS Meeting in Toronto from October 21–23.
The presentations explore the potential of vidofludimus calcium, Immunic…
Recce Pharmaceuticals Ltd chief executive James Graham talked with Proactive about the company’s Phase 3 trial of RECCE® 327 Gel, or R327G, for the treatment of diabetic foot infections in Indonesia and the upcoming review of trial data by an independent Data Monitoring Committee.
Graham said the …
Ondine Biomedical Inc (AIM:OBI, OTC:OBIMF) President and Chief Technology Officer Nicolas Loebel spoke with Proactive's Stephen Gunnion about the company’s £10 million fundraising, positive top-line Phase 3 results and plans to bring its nasal photodisinfection technology to the US market.
Loebel …
면책 조항: 이 페이지에 포함된 팟캐스트와 작품은 Proactive에서 가져온 것입니다. 이 팟캐스트는 소유자의 재산이며 Listen Notes, Inc.와 제휴하거나 보증하지 않습니다.
